rapid
develop
comput
hardwar
softwar
algorithm
drug
screen
design
benefit
much
variou
comput
method
greatli
reduc
time
cost
drug
develop
gener
bioinformat
help
reveal
key
gene
massiv
amount
genom
data
thu
provid
possibl
target
protein
drug
screen
design
supplement
experi
protein
structur
predict
method
provid
protein
structur
reason
precis
biomolecular
simul
multiscal
model
allow
investig
structur
thermodynam
featur
target
protein
differ
level
use
identifi
drug
bind
site
elucid
drug
action
mechan
virtual
screen
search
chemic
librari
provid
possibl
drug
candid
base
drug
bind
site
target
protein
greatli
reduc
amount
possibl
drug
candid
invitro
cell
experi
evalu
efficaci
molecul
addit
virtual
screen
de
novo
drug
design
method
gener
synthesiz
small
molecul
high
bind
affin
provid
anoth
type
computeraid
drug
design
direct
artifici
intellig
eg
machin
learn
deep
learn
play
import
role
aforement
comput
method
thu
drug
develop
review
focu
develop
last
four
comput
method
well
applic
drug
screen
design
nobel
prize
chemistri
award
jointli
martin
karplu
michael
levitt
arieh
warshel
pioneer
contribut
develop
multiscal
model
complex
biochem
system
recogn
import
role
theori
comput
method
play
direct
necessari
complement
experi
applic
biomolecular
simul
identifi
drug
bind
site
elucid
molecular
mechan
diseas
subject
rapid
develop
depend
biolog
problem
studi
multiscal
model
use
biomolecular
simul
combin
quantum
mechan
qm
molecular
mechan
mm
qmmm
use
studi
electron
properti
simul
chemic
reaction
eg
enzym
catalysi
mechan
calcul
spectra
singl
simul
use
elucid
action
mechan
certain
drug
anoth
wide
use
biomolecular
method
molecular
dynam
md
simul
appli
empir
molecular
mechan
mm
forc
field
base
classic
newtonian
mechan
accord
differ
accuraci
requir
allatom
aa
unitedatom
ua
coarsegrain
cg
md
simul
well
explicitimplicit
solvent
model
allow
simul
tempor
spatial
scale
use
facilit
drug
discoveri
gener
md
simul
use
identif
potenti
drug
bind
site
target
protein
calcul
bind
free
energi
target
protein
drug
molecul
action
mechan
drug
molecul
etc
howev
worth
mention
md
simul
also
limit
time
length
scale
current
aamd
simul
explor
timedepend
phenomena
larg
system
viral
capsid
atom
detail
long
microsecond
even
millisecond
therefor
differ
type
simul
method
requir
differ
type
problem
differ
simul
method
advantag
disadvantag
practic
limit
term
size
system
simul
length
simul
achiev
type
phenomena
model
hand
improv
algorithm
fastgrow
data
set
comput
abil
drive
rapid
advanc
multiscal
model
method
provid
power
emerg
paradigm
drug
discoveri
mention
multiscal
biomolecular
simul
use
drug
design
exampl
md
simul
use
identifi
drug
bind
site
target
protein
sever
simpl
tool
eg
fpocket
moreov
multiscal
biomolecular
simul
use
reveal
action
mechan
drug
happen
mainli
molecular
level
clearli
macroscop
effect
molecular
structur
level
cellular
tissu
dynam
drug
target
surpris
complex
biolog
system
challeng
scientif
understand
order
reveal
chang
differ
level
link
interact
network
singl
simul
method
solv
problem
involv
multiscal
simul
method
design
simul
analyz
crossscal
connect
exampl
one
scale
chang
lead
anoth
scale
chang
obviou
challeng
integr
data
simul
across
length
scale
time
scale
current
multiscal
approach
potenti
overcom
limit
directli
combin
differ
level
descript
thu
bring
new
prospect
drug
discoveri
multiscal
simul
play
import
role
studi
biolog
process
show
applic
combin
differ
method
deal
complic
biolog
process
field
recent
year
although
md
simul
wide
use
still
consid
chang
ioniz
state
simul
process
exampl
md
simul
discuss
time
depend
long
timescal
biolog
proton
transport
process
time
depend
protein
chang
ph
also
reveal
therefor
calcul
simul
process
necessari
combin
mont
carlo
mc
approach
perform
timedepend
simul
proton
transport
process
md
approach
perform
ph
depend
protein
model
accord
electrostat
energi
cg
model
obtain
free
energi
proton
state
addit
movement
mc
approach
base
electrostat
energi
cg
model
proton
transport
time
use
make
scale
correspond
rate
constant
predict
transit
state
theori
henc
use
isomorph
probabl
obtain
mc
process
probabl
factor
obtain
transit
state
theori
convert
mc
process
timedepend
simul
addit
simplifi
modif
structurebas
drug
design
must
perform
avail
structur
model
target
protein
provid
xray
diffract
nuclear
magnet
reson
nmr
molecular
simul
homolog
protein
model
etc
keep
mind
complex
cancer
show
divers
phenotyp
multipl
etiolog
onesizefitsal
drug
design
strategi
develop
cancer
chemotherapeut
yield
success
result
late
arjmand
et
al
adopt
seri
method
combin
xray
crystal
structur
molecular
dock
design
synthes
character
novel
chromon
basedcopp
ii
antitumor
inhibitor
gener
obtain
structur
receptor
macromolecul
xcrystal
singlecryst
diffract
techniqu
multidimension
nmr
molecular
model
softwar
use
analyz
physicochem
properti
drug
bind
site
receptor
especi
includ
electrostat
field
hydrophob
field
hydrogen
bond
key
residu
small
molecul
databas
search
drug
design
techniqu
use
identifi
suitabl
molecul
whose
molecular
shape
match
bind
site
receptor
bind
affin
high
molecul
synthes
biolog
activ
test
drug
develop
short
structurebas
drug
design
play
extrem
import
role
drug
design
unlik
structurebas
drug
design
ligandbas
drug
design
search
small
molecul
librari
instead
reli
knowledg
known
molecul
bind
target
macromolecul
interest
use
known
molecul
pharmacophor
model
defin
minimum
necessari
structur
characterist
molecul
must
possess
order
bind
target
deriv
model
use
design
new
molecular
entiti
interact
target
hand
ligandbas
drug
design
also
use
quantit
relationship
qsar
correl
calcul
properti
molecul
experiment
determin
biolog
activ
deriv
predict
activ
new
analog
pharmacophor
model
qsar
model
discuss
detail
follow
session
molecular
dock
predict
interact
pattern
protein
small
molecul
wel
protein
protein
evalu
bind
two
molecul
wide
use
field
drug
screen
design
theoret
basi
process
ligand
receptor
recognit
reli
spatial
shape
match
energi
match
theori
induc
fit
determin
correct
bind
conform
small
molecul
ligand
protein
receptor
format
complex
structur
basi
drug
design
studi
action
mechan
molecular
dock
roughli
divid
rigid
dock
semiflex
dock
flexibl
dock
rigid
dock
structur
molecul
chang
calcul
method
rel
simpl
mainli
studi
degre
conform
match
suitabl
studi
macromolecular
system
acid
system
semiflex
dock
conform
molecul
vari
within
certain
rang
suitabl
deal
interact
protein
small
molecul
gener
structur
small
molecul
freeli
chang
macromolecul
remain
rigid
retain
rotat
amino
acid
residu
ensur
comput
effici
flexibl
dock
simul
system
conform
free
chang
thu
consum
comput
resourc
improv
accuraci
establish
bind
site
molecular
dock
method
import
first
time
collin
success
determin
bind
site
surfac
protein
use
multiscal
algorithm
perform
flexibl
dock
molecul
greatli
promot
develop
molecular
dock
pharmacophor
abstract
descript
molecular
featur
necessari
molecular
recognit
ligand
biolog
macromolecul
explain
structur
divers
ligand
bind
common
receptor
site
drug
molecul
interact
target
macromolecul
produc
geometr
energet
match
activ
conform
target
medicin
chemist
found
differ
chemic
group
drug
molecul
differ
effect
activ
chang
group
great
influenc
interact
drug
target
other
littl
effect
moreov
found
molecul
activ
tend
characterist
therefor
ehrlich
propos
concept
pharmacophor
refer
molecular
framework
atom
activ
essenti
characterist
gund
clarifi
concept
pharmacophor
group
molecul
recogn
receptor
form
structur
featur
molecular
biolog
activ
two
main
method
identif
pharmacophor
one
hand
target
structur
avail
possibl
pharmacophor
structur
infer
analyz
action
mode
receptor
drug
molecul
hand
structur
target
unknown
action
mechan
still
unclear
seri
compound
studi
pharmacophor
inform
group
play
key
role
activ
compound
summar
mean
conform
analysi
molecular
fold
activ
compound
suitabl
construct
model
select
pharmacophor
recognit
process
conform
analysi
use
find
bind
conform
molecul
determin
pharmacophor
recent
year
develop
compound
databas
comput
technolog
virtual
screen
databas
use
pharmacophor
model
wide
use
becom
one
import
mean
discov
lead
compound
qsar
quantit
studi
interact
small
organ
molecul
biolog
macromolecul
contain
correl
calcul
properti
molecul
eg
absorpt
distribut
metabol
small
organ
molecul
live
organ
experiment
determin
biolog
activ
case
unknown
receptor
structur
qsar
method
accur
effect
method
drug
design
drug
discoveri
often
involv
use
qsar
identifi
chemic
structur
could
good
inhibitori
effect
specif
target
low
toxic
nonspecif
activ
develop
relationship
theori
statist
method
structur
inform
introduc
qsar
method
name
sinc
improv
comput
power
accur
determin
structur
mani
biomacromolecul
structurebas
drug
design
gradual
replac
domin
posit
quantit
structureact
relationship
field
drug
design
qsar
advantag
small
amount
calcul
good
predict
abil
still
play
import
role
pharmaceut
research
base
structur
characterist
ligand
target
explor
concept
bioactiv
molecul
accur
reflect
energi
chang
pattern
interact
bioactiv
molecul
receptor
reveal
drugreceiv
mechan
bodi
interact
physicochem
paramet
structur
paramet
seri
drug
fit
quantit
relationship
structur
new
compound
predict
optim
short
actual
research
method
combin
qsar
comput
chemistri
molecular
graphic
power
tool
studi
interact
drug
target
macromolecul
specul
imag
simul
target
establish
relationship
drug
structur
activ
design
drug
fragmentbas
de
novo
design
method
start
small
build
block
initi
molecular
build
block
desir
properti
either
elabor
upon
grow
directli
connect
join
connect
linker
link
process
iter
one
molecul
desir
properti
obtain
two
method
name
structurebas
ligandbas
method
structurebas
de
novo
design
method
search
novel
ligand
use
structur
inform
protein
target
usual
construct
directli
target
protein
bind
site
evalu
calcul
interact
energi
target
protein
ligand
nevertheless
de
novo
ligand
design
method
molecul
structur
protein
target
unknown
new
molecul
suggest
base
structur
analog
known
ligand
molecul
nowaday
proteochemometr
emerg
rel
new
disciplin
drug
discoveri
file
qsar
analysi
power
tool
effici
virtual
screen
show
physicochem
properti
variou
compound
compar
classic
qsar
qm
calcul
use
reactiv
descriptor
ligandbas
qsar
provid
implicit
model
calcul
exact
enthalpi
contribut
proteinligand
interact
howev
ab
initio
fragment
molecular
orbit
calcul
structurebas
qsar
obtain
explicit
model
clear
enthalpi
chang
bind
energi
differ
addit
condit
moreov
also
calcul
free
energi
contribut
ligandtarget
complex
format
structurebas
ligandbas
qsar
model
use
larg
number
ligandtarget
complex
discuss
chang
bind
affin
accur
optim
step
conduct
base
good
predict
interpret
model
key
qsar
model
accur
describ
molecul
qm
approach
provid
better
understand
molecular
structur
characterist
ligand
drug
solv
problem
exist
drug
discoveri
qsar
model
differ
scale
built
accord
differ
comput
precis
multiscaleqsar
research
object
mainli
refer
structur
descript
train
set
involv
small
molecul
macromolecul
micro
meso
macroscop
scale
differ
molecular
approach
use
qm
approach
often
use
perform
precis
calcul
microscal
atombas
qsar
molecular
forc
field
focus
mesoscopicscal
simul
fragmentbas
qsar
coarsegrain
studi
mainli
perform
macroscop
scale
macromoleculebas
qsar
cellbas
qsar
moreov
multiscal
also
reflect
differ
dimens
use
differ
qsar
model
comfa
techniqu
fragmentbas
qsar
complet
skeleton
transit
rgroup
substitut
provid
differ
structur
new
drug
design
besid
deriv
proteochemometr
pcm
kinochemometr
kcm
approach
use
descriptor
protein
kinas
fingerprint
ligand
greatli
increas
effici
well
precis
compar
tradit
qsar
method
multiscal
qsar
provid
effect
predict
drug
design
integr
qsar
systemat
appli
exist
qsar
method
effect
multiscal
de
novo
drug
design
novel
concept
combin
qsar
model
qm
calcul
fragmentbas
drug
discoveri
fbdd
import
explicit
molecular
descriptor
shown
model
molecular
structur
point
view
qm
calcul
assembl
reason
molecular
fragment
object
drug
design
method
produc
certain
novel
molecul
display
highest
biolog
activ
absorpt
metabol
elimin
adm
lowest
toxic
properti
differ
environ
belong
applic
rang
qsar
model
multiscal
de
novo
drug
design
method
effici
handl
larg
amount
biochemicalclin
data
obtain
chemic
characterist
order
improv
properti
drug
molecul
consid
effect
safer
method
discov
new
therapeut
agent
decis
tree
dt
simpl
interpret
predict
machin
learn
method
ordinarili
two
fundament
step
select
properti
prune
decis
tree
build
select
properti
consid
intern
node
branch
repres
test
result
molecul
leaf
node
classif
label
order
avoid
complex
decis
tree
prune
program
use
prune
establish
tree
dt
typic
classif
algorithm
wide
use
predict
auxiliari
diagnosi
diseas
manag
decisionmak
classif
mode
creat
metabol
disord
data
mine
diabet
etc
abdul
et
al
develop
taskbas
chemic
toxic
predict
framework
use
decis
tree
obtain
optimum
number
featur
collect
thousand
effect
help
chemist
perform
prescreen
toxic
compound
effect
artifici
neural
network
ann
achiev
problemsolv
mimick
brain
function
brain
appli
inform
obtain
past
experi
solv
new
problem
neural
network
construct
system
neuron
reach
new
decis
classif
predict
base
previou
experi
process
element
similar
neuron
massiv
process
element
organ
layer
includ
three
type
input
hidden
output
layer
ann
benefit
high
selforgan
robust
fault
toler
wide
appli
prognosi
evalu
earli
prevent
diseas
lorenzo
et
al
use
interpret
ann
predict
biophys
properti
therapeut
monoclon
antibodi
includ
melt
temperatur
aggreg
onset
temperatur
interact
paramet
function
ph
salt
concentr
amino
acid
composit
artifici
neural
network
first
heyday
molecular
informat
drug
discoveri
approxim
two
decad
ago
current
wit
renew
interest
adapt
advanc
neural
network
architectur
pharmaceut
research
borrow
idea
deep
learn
field
compar
field
life
scienc
applic
drug
discoveri
still
limit
support
vector
machin
svm
one
promis
machin
learn
method
use
molecular
descriptor
construct
predict
qsar
model
deal
highdimension
dataset
ann
multipl
linear
regress
analysi
use
construct
linear
nonlinear
model
compar
result
gain
svm
linear
model
svm
approach
use
space
map
point
separ
differ
classif
maxim
rang
differ
categori
point
nonlinear
model
svm
use
nucleu
map
transform
highdimens
space
linear
classif
present
svm
approach
wide
use
model
differ
scale
drug
discoveri
k
nearest
neighbor
knn
one
simplest
intuit
algorithm
among
machin
learn
method
usual
jointli
use
select
algorithm
featur
space
use
classif
regress
base
exampl
learn
normal
molecul
classifi
vote
closest
neighbor
result
common
class
molecul
distribut
closest
neighbor
valu
k
number
closest
neighbor
base
ligandbas
virtual
screen
knn
view
prolong
form
chemic
similar
search
supervis
learn
top
search
result
predict
best
bioactiv
weber
et
al
tri
two
machin
learn
algorithm
classif
knn
rf
analyz
genotypephenotyp
dataset
hiv
proteas
revers
transcriptas
rt
result
algorithm
high
accuraci
predict
drug
resist
proteas
rt
inhibitor
random
forest
rf
ensembl
learn
approach
involv
build
multipl
dt
base
train
exampl
similar
knn
algorithm
also
use
classif
predict
regress
compar
dt
imposs
rf
overfit
data
rf
use
bioactiv
data
classif
toxic
model
drug
target
predict
etc
wang
et
al
use
rf
approach
model
bind
affin
proteinligand
proteas
complex
trypsin
complex
carbon
anhydras
complex
demonstr
individu
represent
model
construct
protein
famili
reason
way
predict
affin
one
particular
protein
famili
current
multiscal
model
predict
toxic
activ
adm
properti
differ
protein
microbi
target
integr
differ
genom
proteom
cheminformat
play
import
role
ration
drug
discoveri
qsar
model
becom
main
auxiliari
tool
achiev
virtual
screen
variou
pharmacolog
characterist
although
qsar
model
wide
use
search
design
new
drug
classic
qsar
model
predict
activ
toxic
one
biomolecul
one
certain
target
howev
multitarget
qsar
mtqsar
use
carri
ration
drug
design
multipl
target
provid
better
way
understand
variou
pharmacolog
characterist
molecul
includ
antibacteri
activ
toxic
furthermor
uniform
multitask
model
base
quantit
structur
biolog
effect
relationship
mtkqsber
use
lot
research
model
built
ann
topolog
indic
predict
biolog
activ
toxic
correctli
classifi
compound
experiment
condit
meanwhil
model
use
perturb
model
form
structuralact
relationship
site
infect
drug
ptml
model
chembl
model
appli
infecti
diseas
immunolog
cancer
wide
current
mtkqsber
model
abl
carri
insilico
design
virtual
screen
antibacteri
drug
effici
antibacteri
drug
good
biosafeti
method
provid
power
tool
silico
screen
reason
drug
deep
learn
network
concept
close
relat
ann
learn
concept
layer
word
multipl
learn
approach
rang
low
high
level
molecular
descriptor
select
deep
learn
method
automat
select
represent
origin
data
highdimension
data
therefor
allow
deep
learn
appli
model
build
drug
discoveri
convolut
neural
network
cnn
commonli
use
made
great
progress
comput
vision
commun
appli
drug
design
field
includ
de
novo
drug
molecul
identif
protein
engin
gene
express
analysi
rapid
develop
deep
learn
concept
cnn
molecular
model
tool
box
equip
potenti
gamechang
method
judg
success
recent
pioneer
studi
convinc
modern
deep
learn
architectur
use
come
age
big
data
analysi
pharmaceut
research
toxic
predict
genom
mine
chemogenom
applic
name
immedi
area
applic
kiminori
et
al
develop
fundament
technolog
predict
resist
free
cancer
cell
fluorin
pyrimidin
anticanc
drug
deep
learn
morpholog
imag
data
taken
imag
cai
et
al
develop
deep
learn
approach
term
deep
human
etheragogorel
gene
herg
predict
herg
blocker
small
molecul
drug
discoveri
postmarket
surveil
group
found
deepherg
model
built
multitask
deep
neural
network
dnn
algorithm
outperform
built
singletask
dnn
svm
rf
drug
develop
technolog
usual
includ
artifici
intelligencebas
aibas
techniqu
ai
applic
concentr
limit
task
moreov
current
ai
direct
patient
specif
problem
make
subject
infer
like
doctor
overal
physic
context
patient
subfield
ai
ml
success
use
train
qualiti
exampl
howev
process
timeconsum
costli
develop
ml
techniqu
applic
exist
algorithm
process
massiv
amount
digit
data
result
higher
requir
comput
hardwar
also
increas
clinic
cost
dl
also
subset
ml
process
big
data
creat
pattern
layer
neuron
howev
difficult
understand
decis
obtain
algorithm
ml
method
achiev
great
success
field
chemoinformat
design
discov
new
drug
import
innov
combin
ml
method
big
data
analysi
predict
extens
biolog
featur
vital
discov
secur
effici
drug
integr
structur
genet
inform
pharmacolog
data
scale
molecular
organ
addit
dl
approach
proven
promis
way
effici
learn
larg
varieti
dataset
modern
novel
drug
discoveri
multiscal
model
drug
excit
system
critic
experi
singl
system
scale
reveal
underli
effect
multipl
drug
interact
comput
base
approach
predict
emerg
effect
drug
excitatori
rhythm
may
form
interact
technologydriven
process
drug
diseas
screen
industri
research
develop
academia
patientori
medic
clinic
potenti
farreach
implic
million
peopl
affect
arrhythmia
year
benefit
improv
risk
stratif
drugbas
intervent
much
progress
made
develop
multiscal
comput
model
simul
approach
predict
effect
cardiac
ion
channel
block
drug
structur
model
ion
channel
interact
drug
critic
approach
current
futur
drug
discoveri
effort
model
drug
receptor
site
within
ion
channel
structur
use
identifi
key
drugchannel
interact
site
drug
interact
cardiac
ion
channel
model
atom
scale
simul
dock
md
simul
well
level
channel
function
simul
drug
effect
channel
behavior
structur
model
drugchannel
interact
atom
scale
may
ultim
allow
design
novel
highaffin
subtyp
select
drug
specif
target
receptor
cardiac
neurolog
disord
world
health
organ
state
cancer
remain
one
danger
diseas
today
consid
cancer
multifactori
diseas
increas
interest
multitarget
compound
target
multipl
intracellular
pathway
howev
studi
larg
data
set
analysi
anticanc
compound
difficult
larg
amount
data
high
data
complex
exampl
chembl
databas
compil
big
dataset
heterogen
preclin
assay
bediaga
et
al
report
ptmllda
model
chembl
dataset
preclin
determin
anticanc
compound
ptml
model
combin
perturb
theori
pt
idea
ml
method
solv
similar
problem
compar
model
ptml
model
report
speckplanch
et
al
conclud
one
predict
activ
multipl
cancer
speckplanch
et
al
also
deriv
multitask
mtk
chemic
inform
model
combin
broto
moreau
autocorrel
ann
dataset
contain
peptid
case
model
use
virtual
design
screen
peptid
potenti
anticanc
activ
differ
cancer
cell
line
low
cytotox
varieti
healthi
mammalian
cell
model
show
greater
train
predict
test
accuraci
addit
due
inher
complex
tumor
necessari
analyz
growth
differ
scale
includ
mani
phenomena
occur
variou
spatial
scale
tissu
molecular
length
complex
cancer
develop
manifest
least
three
scale
distinguish
describ
mathemat
model
name
microscal
mesoscal
macroscal
wang
et
al
conduct
number
studi
use
multiscal
model
identif
combin
therapi
drug
target
method
base
quantif
relationship
intracellular
epiderm
growth
factor
receptor
egfr
signal
kinet
lung
cancer
extracellular
epiderm
growth
factor
egf
stimul
multicellular
growth
multiscal
model
tumor
combin
system
pharmacolog
contribut
develop
practic
smart
drug
produc
comprehens
systemlevel
approach
determin
dynam
effect
exist
new
drug
preclin
trial
model
organ
individu
patient
addit
mathemat
comput
studi
provid
better
way
understand
mani
factor
influenc
effect
drug
thu
help
uncov
better
way
therapeut
interfer
diseas
multiscal
model
also
use
identifi
pathophysiolog
process
allow
diseas
stage
mani
case
like
cancer
treatment
vari
depend
stage
diseas
model
help
determin
prognosi
import
clinic
determin
help
determin
right
type
medic
administ
discov
sever
model
focu
neuron
network
level
includ
cutsuridi
moustafa
alzheim
diseas
lytton
epilepsi
ann
class
ml
techniqu
use
clinic
analysi
big
data
includ
relat
drug
test
critic
drug
discoveri
addit
anastasio
introduc
process
algebra
comput
technolog
wide
use
analyz
complex
comput
system
use
calcul
neurolog
sirci
et
al
describ
network
map
theori
use
identifi
similar
differ
differ
pharmacolog
agent
type
studi
drug
node
edg
drug
repres
chemic
transcriptionbas
interact
character
drug
addit
ferreira
da
costa
et
al
report
first
ptml
pt
ml
studi
larg
number
chembl
dataset
preclin
determin
compound
dopamin
pathway
protein
molecular
dock
ml
model
use
solv
specif
protein
model
explain
larg
complex
larg
data
set
preclin
assay
report
public
databas
pt
model
hand
allow
us
predict
properti
queri
compound
molecular
system
experiment
analysi
multipl
boundari
condit
base
previous
known
refer
case
work
best
ptml
model
found
train
extern
valid
seri
accuraci
hansch
model
classic
method
solv
quantit
structur
bind
relationship
qsbr
pharmacolog
medicin
chemistri
abeijon
et
al
develop
new
ptqsbr
hansch
model
base
pt
qsbr
method
larg
number
drug
report
chembl
focus
protein
express
hippocampu
brain
alzheim
diseas
ad
patient
decompos
risk
caus
combin
complex
system
produc
diseas
prevent
improv
diseas
multistag
multitarget
multidrug
techniqu
multiscal
model
gradual
grasp
aid
hepat
c
influenza
diseaserel
virus
current
work
hard
develop
antivir
drug
target
howev
uniqu
structur
prolifer
viru
pose
natur
challeng
drug
develop
virus
cellular
structur
metabol
system
must
replic
prolifer
host
cell
therefor
difficult
find
compound
target
viral
target
without
affect
normal
function
host
cell
present
main
way
antivir
drug
work
inhibit
viral
replic
howev
mani
tool
use
viru
replic
come
human
cell
ribosom
correspond
antivir
drug
also
bring
great
side
effect
human
bodi
therefor
discoveri
drug
requir
introduct
multiscal
model
screen
drug
inhibit
viral
replic
reduc
damag
human
bodi
far
retrovir
infect
hiv
incur
diseas
chembl
manag
big
data
capabl
complex
dataset
make
inform
difficult
analyz
dataset
describ
numer
featur
predict
new
drug
retrovir
infect
without
proper
model
imposs
make
full
use
featur
henc
et
al
propos
ptml
model
chembl
dataset
effici
use
preclin
experiment
analysi
antiretrovir
compound
pt
oper
base
multicondit
move
averag
combin
differ
function
simplifi
manag
data
ptml
model
propos
first
consid
multipl
featur
combin
preclin
experiment
antiretrovir
test
order
simultan
explor
antibacteri
activ
gramneg
pathogen
vitro
safeti
relat
absorpt
distribut
metabol
elimin
toxic
admet
speckplanche
et
al
propos
first
mtkqsber
model
accuraci
model
train
predict
test
set
higher
also
develop
chemoinformat
model
simultan
predict
anticocci
activ
vitro
safeti
best
model
display
accuraci
around
train
predict
test
set
addit
focus
explor
antihepat
c
viru
hcv
accuraci
shown
train
predict
test
set
higher
use
model
cytotox
one
main
concern
earli
develop
peptidebas
drug
kleandrova
et
al
introduc
first
multitask
process
mtk
comput
model
focus
predict
antibacteri
activ
peptid
cytotox
gonzalezdiaz
et
al
develop
model
call
lnnalma
gener
complex
network
aid
preval
respect
preclin
activ
antihiv
drug
multiscal
model
also
imperfect
limit
model
express
simplif
real
life
model
repres
everyth
happen
system
model
contain
specif
assumpt
model
vari
wide
comprehens
qualiti
util
word
model
solv
limit
problem
henc
need
integr
differ
comput
model
data
order
make
full
use
model
comput
method
come
play
signific
role
drug
screen
design
multiscal
biomolecular
simul
help
identifi
drug
bind
site
target
macromolecul
elucid
drug
action
mechan
virtual
screen
effici
search
massiv
chemic
databas
lead
compound
de
novo
drug
design
provid
altern
power
way
design
drug
molecul
scratch
use
build
block
summar
abstract
previou
success
drug
discoveri
ml
revolution
comput
method
drug
screen
design
may
greatli
improv
effici
precis
big
data
era
frequent
emphas
differ
model
effici
algorithm
eg
dimension
reduct
need
integr
properli
achiev
comprehens
studi
biolog
process
multipl
scale
well
accur
effect
drug
screen
design
integr
comput
method
acceler
drug
develop
help
identifi
effect
therapi
novel
action
mechan
ultim
appli
varieti
complex
biolog
system
